\n\n\n\n\t\t\n\t\t\tInogen\n\t\t\thttp://www.inogen.net/\n\t\t
\n\t\t\n\t\t\tWatch Company\n\t\t\tGet Widget\n\t\t
\n\tInogen was founded in 2001 to develop products that improve quality of life and increase freedom and mobility for respiratory disease sufferers, predominantly Chronic Obstructive Pulmonary Disease...More»
\n\t\t\tInogen was founded in 2001 to develop products that improve quality of life and increase freedom and mobility for respiratory disease sufferers, predominantly Chronic Obstructive Pulmonary Disease (COPD) patients. COPD is the fourth leading cause of death in the United States, and the only major disease with an ever increasing death rate. By 2020 COPD is predicted to become the third leading cause of death worldwide. COPD affects an estimated 30 million people in the US and over 100 million worldwide.
Inogen has assembled a team of experienced health care entrepreneurs, skilled technologists, well known clinicians and home healthcare veterans to produce innovative solutions to respiratory home healthcare challenges. Inogen\'s team is passionate about their mission and committed to serving the unique needs of respiratory patients and providers.«Less
Overview
\n\t\t\t\tLocation: \tGoleta, CA, United States\n
\n\t\t\t\tIndustry: Medical Devices & Equipment
\n\t\t\t\tEmployees: 85
\n\t\t\t\tTags:\n\t\t\t\tportable oxygen system,\n\t\t\t\tmedical,\n\t\t\t\tconcentrator,\n\t\t\t\toxygen therapy,\n\t\t\t\tPortable,\n\t\t\t\tCOPD,\n\t\t\t\toxygen system,\n\t\t\t\toxygen,\n\t\t\t\trespiratory disease,\n\t\t\t\toxygen concentrator,\n\t\t\t\tmedical device\n\t\t\t\t
\n\t\t\tFinancials
\n\t\t\t\tLatest Funding: Series A - $22M (02/26/2007)
\n\t\t\t\tInvestors:\n\t\t\t\t\t\n\t\tNovo A/S\n\t\t\t\t
\n\t\t\tMarket
\n\t\t\t\tCompetitors:\n\t\t\t\t\t\tOxygen Concentrator Inc.,\n\t\t\t\t\t\tInspired Technologies,\n\t\t\t\t\t\tSeQual Technologies\n\t\t\t\t
\n\n\t\t\t\tRelated Companies:\n\t\t\t\t\tInspired Technologies,\n\t\t\t\t\tSeQual Technologies\n\t\t\t\t
\n\t\t\t